253 related articles for article (PubMed ID: 23254375)
1. Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake.
Radke AK; Holtz NA; Gewirtz JC; Carroll ME
Psychopharmacology (Berl); 2013 May; 227(1):117-26. PubMed ID: 23254375
[TBL] [Abstract][Full Text] [Related]
2. Intracranial self-stimulation reward thresholds during morphine withdrawal in rats bred for high (HiS) and low (LoS) saccharin intake.
Holtz NA; Radke AK; Zlebnik NE; Harris AC; Carroll ME
Brain Res; 2015 Mar; 1602():119-26. PubMed ID: 25582876
[TBL] [Abstract][Full Text] [Related]
3. Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures.
Harris AC; Hanes SL; Gewirtz JC
Psychopharmacology (Berl); 2004 Nov; 176(3-4):266-73. PubMed ID: 15164157
[TBL] [Abstract][Full Text] [Related]
4. Protracted manifestations of acute dependence after a single morphine exposure.
Rothwell PE; Thomas MJ; Gewirtz JC
Psychopharmacology (Berl); 2012 Feb; 219(4):991-8. PubMed ID: 21833504
[TBL] [Abstract][Full Text] [Related]
5. Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure.
Rothwell PE; Thomas MJ; Gewirtz JC
Neuropsychopharmacology; 2009 Sep; 34(10):2285-95. PubMed ID: 19494807
[TBL] [Abstract][Full Text] [Related]
6. Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety.
Harris AC; Gewirtz JC
Psychopharmacology (Berl); 2004 Jan; 171(2):140-7. PubMed ID: 13680079
[TBL] [Abstract][Full Text] [Related]
7. Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia.
Harris AC; Rothwell PE; Gewirtz JC
Psychopharmacology (Berl); 2008 Mar; 196(4):649-60. PubMed ID: 18026718
[TBL] [Abstract][Full Text] [Related]
8. Effects of age, but not sex, on elevated startle during withdrawal from acute morphine in adolescent and adult rats.
Radke AK; Gewirtz JC; Carroll ME
Behav Pharmacol; 2015 Aug; 26(5):485-8. PubMed ID: 26154436
[TBL] [Abstract][Full Text] [Related]
9. The acoustic startle response as a measure of behavioral dependence in rats.
Mansbach RS; Gold LH; Harris LS
Psychopharmacology (Berl); 1992; 108(1-2):40-6. PubMed ID: 1410145
[TBL] [Abstract][Full Text] [Related]
10. Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male rats.
Ayoub SM; Smoum R; Farag M; Atwal H; Collins SA; Rock EM; Limebeer CL; Piscitelli F; Iannotti FA; Lichtman AH; Leri F; Di Marzo V; Mechoulam R; Parker LA
Psychopharmacology (Berl); 2020 Sep; 237(9):2753-2765. PubMed ID: 32556401
[TBL] [Abstract][Full Text] [Related]
11. Cocaine withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake.
Radke AK; Zlebnik NE; Carroll ME
Pharmacol Biochem Behav; 2015 Feb; 129():51-5. PubMed ID: 25482327
[TBL] [Abstract][Full Text] [Related]
12. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
Azar MR; Jones BC; Schulteis G
Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
[TBL] [Abstract][Full Text] [Related]
13. Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence.
Kalinichev M; Holtzman SG
J Pharmacol Exp Ther; 2003 Feb; 304(2):603-9. PubMed ID: 12538812
[TBL] [Abstract][Full Text] [Related]
14. Anxiogenic-like effects of opiate withdrawal seen in the fear-potentiated startle test, an interdisciplinary probe for drug-related motivational states.
Fendt M; Mucha RF
Psychopharmacology (Berl); 2001 May; 155(3):242-50. PubMed ID: 11432686
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
16. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal.
Kosten TA
Eur J Pharmacol; 1994 Mar; 254(1-2):59-63. PubMed ID: 8206117
[TBL] [Abstract][Full Text] [Related]
17. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
[TBL] [Abstract][Full Text] [Related]
18. Altered Acoustic Startle Reflex, Prepulse Inhibition, and Peripheral Brain-Derived Neurotrophic Factor in Morphine Self-Administered Rats.
Lee BH; Park TY; Lin E; Li H; Yang CH; Choi KH
Int J Neuropsychopharmacol; 2017 May; 20(5):383-391. PubMed ID: 27927738
[TBL] [Abstract][Full Text] [Related]
19. Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure.
Schulteis G; Heyser CJ; Koob GF
Psychopharmacology (Berl); 1997 Jan; 129(1):56-65. PubMed ID: 9122364
[TBL] [Abstract][Full Text] [Related]
20. Affective and neuroendocrine effects of withdrawal from chronic, long-acting opiate administration.
Hamilton KL; Harris AC; Gewirtz JC
Brain Res; 2013 Nov; 1538():73-82. PubMed ID: 24076207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
